Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
328.20
Jul 24 • 3:59 PM ET Dollar change-27.28 Percentage change(-7.67%)
Aftermarket Close
328.20
Aftermarket • 7:35 PM ET Dollar change0.00 Percentage change(0.00%)
Jul 24, 8:31 PMProfit-taking after Q2 earnings beat and raised guidance triggers 7.7% drop
Index
S&P 500
Market Cap
23.10B
Enterprise Value
22.98B
Income
564.90M
Sales
3.33B
Book/sh
42.47
Cash/sh
6.19
Employees
10800
IPO
Mar 17, 1980
P/E
41.96
Forward P/E
33.08
PEG
2.14
P/S
6.94
P/B
7.73
P/C
53.00
P/FCF
52.87
EV/EBITDA
25.18
EV/Sales
6.91
Quick Ratio
2.12
Current Ratio
2.82
Debt/Eq
0.11
LT Debt/Eq
0.10
Option/Short
Yes / Yes
EPS (ttm)
7.82
EPS next Y
9.92
EPS next Q
2.18
EPS this Y
22.62%
EPS next Y
11.00%
EPS next 5Y
15.45%
EPS past 3/5Y
-4.22% 8.26%
Sales past 3/5Y
2.14% 7.45%
EPS Y/Y TTM
17.07%
Sales Y/Y TTM
12.42%
EPS Q/Q
18.81%
Sales Q/Q
13.86%
Insider Own
0.64%
Insider Trans
-0.82%
Inst Own
102.78%
Inst Trans
3.76%
ROA
14.07%
ROE
19.09%
ROIC
17.20%
Gross Margin
36.82%
Oper. Margin
21.97%
Profit Margin
16.98%
SMA20
-7.87%
SMA50
-1.95%
SMA200
15.94%
Trades
Shs Outstand
70.40M
Shs Float
69.93M
52W High
386.00 -14.97%
52W Low
223.83 46.63%
Volatility
5.14% 2.90%
ATR (14)
11.46
RSI (14)
36.54
Beta
1.14
Rel Volume
1.86
Avg Volume
811.55K
Volume
1,509,059
Perf Week
-8.39%
Perf Month
-3.59%
Perf Quarter
5.97%
Perf Half Y
32.46%
Perf YTD
19.28%
Perf Year
17.59%
Perf 3Y
-12.73%
Perf 5Y
-13.87%
Perf 10Y
320.66%
Prev Close
355.48
Price
328.20
Change
-7.67%
Date Action Analyst Rating Change Price Target Change
Jul-13-26Initiated BNP Paribas Exane Outperform $447
Jun-09-26Upgrade Barclays Equal Weight → Overweight $400
Jun-02-26Resumed Wolfe Research Outperform $375
Dec-02-25Initiated Morgan Stanley Equal-Weight $285
Sep-15-25Initiated Rothschild & Co Redburn Buy $311
Jun-24-25Initiated Barclays Equal Weight $245
Mar-18-25Initiated Evercore ISI Outperform $275
Feb-14-25Upgrade Deutsche Bank Hold → Buy $250
Jan-08-25Initiated Citigroup Buy $400
Dec-13-24Initiated Wolfe Research Peer Perform
Jul-23-26 05:08PM
03:01PM
06:07AM
06:00AM
Jul-21-26 04:00PM
08:07AM Loading…
Jul-17-26 08:07AM
08:02AM
Jul-07-26 06:00AM
Jul-01-26 04:30PM
Jun-01-26 04:30PM
May-20-26 05:24PM
May-14-26 06:46AM
May-12-26 02:16AM
Apr-28-26 06:00AM
Apr-24-26 03:05AM
12:51PM Loading…
Apr-23-26 12:51PM
12:47PM
07:19AM
06:07AM
06:00AM
02:12AM
Apr-09-26 06:00AM
Mar-31-26 11:46AM
Mar-13-26 11:55AM
Mar-10-26 01:03PM
12:06AM
Mar-09-26 05:07PM
04:30PM
Mar-05-26 06:43PM
Mar-03-26 11:40AM
06:00AM Loading…
Feb-27-26 06:00AM
Feb-25-26 09:50AM
Feb-24-26 02:40PM
Feb-23-26 11:24PM
09:55AM
Feb-20-26 09:30AM
08:00AM
Feb-19-26 12:37AM
Feb-17-26 04:00PM
09:45AM
Feb-15-26 12:09PM
Feb-13-26 11:40AM
07:13AM
Feb-12-26 01:07PM
12:32PM
09:30AM
07:10AM
07:02AM
06:11AM
06:10AM
06:00AM
Feb-11-26 11:00AM
Feb-10-26 10:08PM
09:15AM
Feb-09-26 10:24AM
Feb-07-26 12:09PM
Feb-06-26 10:08PM
Feb-05-26 10:00AM
Feb-03-26 01:17PM
Jan-30-26 09:55AM
Jan-29-26 06:00AM
Jan-28-26 11:40AM
Jan-25-26 08:02AM
Jan-23-26 04:34PM
01:50PM
03:58AM
Jan-22-26 12:00PM
10:43AM
09:09AM
08:38AM
Jan-21-26 09:35AM
Jan-20-26 06:00AM
Jan-19-26 08:10AM
Jan-15-26 07:19AM
Jan-14-26 12:50PM
Jan-13-26 09:55AM
08:09AM
Jan-12-26 11:40AM
06:00AM
06:00AM
Jan-07-26 03:38PM
Jan-04-26 11:39PM
Dec-17-25 10:28AM
Dec-12-25 06:00AM
Dec-11-25 08:32AM
Dec-10-25 06:00AM
Dec-05-25 11:30AM
Dec-04-25 11:30AM
08:45AM
Dec-03-25 11:01PM
Nov-26-25 02:18PM
Nov-21-25 03:01AM
Nov-13-25 11:37PM
Nov-12-25 09:33AM
Nov-11-25 10:56AM
Nov-07-25 12:46PM
12:41PM
Nov-06-25 10:31PM
01:25PM
01:22PM
West Pharmaceutical Services, Inc. engages in the design, manufacture, and sale of containment and delivery systems for injectable drugs and healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions, drug delivery systems, analytical lab services, and other integrated services and solutions, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Non-Independent Chair of the BoardMr. Eric Mark Green
Senior VP & CFOMr. Robert W. McMahon C.M.A.
Chief HR Officer & Senior VPMs. Annette F. Favorite
SVP & Chief Proprietary Segment OfficerMr. Shane A. Campbell
VP of Finance & Chief Accounting OfficerMr. Chad R. Winters
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hofmann Thomas WDirectorMay 07 '26Proposed Sale322.123,3841,090,051May 07 03:34 PM
Favorite Annette FSr. VP & Chief HR OfficerApr 27 '26Option Exercise83.472,817235,13519,645Apr 29 12:22 PM
Favorite Annette FSr. VP & Chief HR OfficerApr 27 '26Sale305.202,817859,75316,828Apr 29 12:22 PM
Winters ChadVP, Chief Accounting OfficerApr 27 '26Option Exercise173.22896155,2052,419Apr 29 12:19 PM
Winters ChadVP, Chief Accounting OfficerApr 27 '26Sale300.67896269,3991,523Apr 29 12:19 PM